Search
Login
Register
Menu
Last issue
Home
News
CongressUpdate
Guidelines
Specials
Links
Reimbursement News
All
All
BJH articles
Blog articles
Specials
Search
Forgot Password?
Not a member yet? Register here
Home
/
General
/ Article: PP52 Daratumumab: Blessing for the patient, but hell for the clinical lab
“Article: Highlights in squamous cell carcinoma of the head and neck” has been added to your cart.
View cart
Article: PP52 Daratumumab: Blessing for the patient, but hell for the clinical lab
€
3.03
Article: PP52 Daratumumab: Blessing for the patient, but hell for the clinical lab quantity
Add to cart
SKU:
product-article-16322
Category:
General
Description
Description
PP52 Daratumumab: Blessing for the patient, but hell for the clinical lab
Related products
1 year subscription print edition of the Belgian Journal of Hematology (BJH)
€
209.83
Add to cart
Article: Highlights in urologic cancer
€
3.03
Add to cart
1 year access Online Belgian Journal of Hematology (BJH)
€
71.94
Add to cart
Article: Highlights in breast cancer
€
3.03
Add to cart